GlassScriptPhysician profile
Ayush Amin
NPI 1558822890
$5,133.19
in general payments reported to CMS, 2019-2025
10 companies · $2,631 in 2025
The $2,631 reported for 2025 was more than what 78% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $150 · 2023: $68.68 · 2024: $2,283 · 2025: $2,631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,145 · Travel and Lodging: $1,838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,145.48 |
| Travel and Lodging | $1,837.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,383.13 | 2024-2025 | Indigo System |
| Abbott Laboratories | $1,465.83 | 2024 | Optis, Perclose Proglide |
| Inari Medical, INC. | $571.75 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $301.62 | 2024-2025 | Obsidio |
| Genentech USA, INC. | $150.00 | 2020 | |
| Medtronic, INC. | $91.15 | 2023-2024 | Kyphon Express II Kyphopak Tray |
| Stryker Corporation | $82.50 | 2025 | Flowtriever |
| Terumo Medical Corporation | $32.55 | 2024 | Angio-Seal, Azur Cx Detachable |
| W. L. Gore & Associates, INC. | $29.16 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Siemens Medical Solutions USA, INC. | $25.50 | 2024 | Varian Cryocare Touch System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayush Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.